Attached files

file filename
EX-31.1 - EX-31.1 - ABBOTT LABORATORIESa17-13353_1ex31d1.htm
EX-32.2 - EX-32.2 - ABBOTT LABORATORIESa17-13353_1ex32d2.htm
EX-32.1 - EX-32.1 - ABBOTT LABORATORIESa17-13353_1ex32d1.htm
EX-31.2 - EX-31.2 - ABBOTT LABORATORIESa17-13353_1ex31d2.htm
10-Q - 10-Q - ABBOTT LABORATORIESa17-13353_110q.htm

Exhibit 12

 

Abbott Laboratories and Subsidiaries

 

Computation of Ratio of Earnings to Fixed Charges

 

(Unaudited)

 

(dollars in millions)

 

 

 

Six Months Ended

 

 

 

June 30, 2017

 

Earnings from Continuing Operations

 

$

656

 

Add (deduct):

 

 

 

Taxes on earnings

 

375

 

Capitalized interest cost, net of amortization

 

(6

)

Noncontrolling interests

 

8

 

 

 

 

 

Earnings from Continuing Operations, as adjusted

 

1,033

 

 

 

 

 

Fixed Charges:

 

 

 

Interest on long-term and short-term debt

 

440

 

Capitalized interest cost

 

14

 

Rental expense representative of an interest factor

 

57

 

 

 

 

 

Total Fixed Charges

 

511

 

 

 

 

 

Total adjusted earnings available for payment of fixed charges

 

$

1,544

 

 

 

 

 

Ratio of earnings to fixed charges

 

3.0

 

 

NOTE:   For the purpose of calculating this ratio, (i) earnings from continuing operations have been calculated by adjusting earnings for taxes on earnings; interest expense; capitalized interest cost, net of amortization; noncontrolling interests; and the portion of rentals representative of the interest factor, (ii) Abbott considers one-third of rental expense to be the amount representing return on capital, and (iii) fixed charges comprise total interest expense, including capitalized interest and such portion of rentals.